Table 3. Validation of the results by qRT-PCR analysis.
Gene | SK-OV-3cycling vs.control foldchange(array/qRT-PCR) | SK-OV-3chronic vs.control foldchange(array/qRT-PCR) | PC-3 cyclingvs. controlfold change(array/qRT-PCR) | PC-3 chronicvs. controlfold change(array/qRT-PCR) | WM793Bcycling vs.controlfoldchange(array/qRT-PCR) | WM793B chronic vs. control foldchange (array/qRT-PCR) |
Il8 | 9.1/ 6.2# | 1.8/2.2# | 6.5/3.5 | 9.2/4.5 | 0.9/0.65 | 1.0/1.0 |
AREG | 2.7/1.75# | 0.15/0.5# | 2.4/1.8* | 1.15/0.8* | Low or noexpression | Low or noexpression |
HBEGF | 5.7/2.25# | 1.0/1.45# | 3.0/0.86 | 2.4/1.8 | Low/1.45 | Low/0.75 |
EPHA2 | 4.4/2.2* | 1.8/2.1* | 1.0/1.3* | 0.82/0.8* | 1.3/1.25* | 0.9/1.0 |
PLAU | 4.2/1.8 | 2.1/1.6 | 2.4/2.1* | 1.4/0.6* | Low or noexpression | Low or noexpression |
CXCL2 | 2.3/2.9# | 0.25/1.6 | 3.4/3.1* | 3.7/2.3* | 0.2/0.3* | 0.8/0.7 |
In bold are results showing the differential gene expression between cycling and chronic samples assessed by qRT-PCR. The results marked with * are statistically significant (p<0.05; U Mann-Whitney test), whereas those marked with # have p = 0.051.